Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series

BACKGROUND/AIM: Biologics represent a key therapeutic option in inflammatory bowel disease (IBD), but are associated with several side effects. Post-marketing surveillance, through a spontaneous adverse drug reactions (ADRs) monitoring system, is essential to assess the safety profile of biologics....

Descripción completa

Detalles Bibliográficos
Autores principales: Larussa, Tiziana, Basile, Antonio, Palleria, Caterina, Iannelli, Chiara, Vero, Ada, Giubilei, Lidia, De Sarro, Caterina, Suraci, Evelina, Marasco, Raffaella, Imeneo, Maria, Russo, Emilio, Abenavoli, Ludovico, De Sarro, Giovambattista, Luzza, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357365/
https://www.ncbi.nlm.nih.gov/pubmed/34430850
http://dx.doi.org/10.15386/mpr-1897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357365/
https://www.ncbi.nlm.nih.gov/pubmed/34430850
http://dx.doi.org/10.15386/mpr-1897

Ejemplares similares